MedTrace Logo

Oral Intake of Mg in Controlled Asthmatic Patients

NCT06721247 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2025-08-14

No results posted yet for this study

Summary

The goal of this clinical trial is to assess the efficacy of oral magnesium supplements in controlled asthmatic patients for proper effective asthma management to reduce frequency of asthma exacerbation \& to test the effect of oral magnesium supplementation on improvement of both clinical symptoms and lung functions in patients with bronchial asthma.. The main questions it aims to answer are:

• Can oral supplementation of magnesium play a role in decrease the number of bronchial asthma exacerbations , number of ER visits , number of doctor visits and improve lung function ? Researchers will compare patients on usual treatment according to GINA guidelines 2024 group B and those taking oral magnesium together with the usual group A .

Participants will:

* Take oral magnesium treatment with usual asthma medications according to GINA guidelines (2024) every day for 1year
* Visit the clinic once every 2 weeks for checkups and tests
* Keep a diary of their day and night symptoms and the number of times they had activity limitation due to asthma and the number of use reliever.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Magnesium

oral intake of magnesium for asthmatic patients with dose 200 mg per day for one year in addition to usual asthmatic treatment according to GINA guidelines 2024

DRUG

ICS+LABA

inhaled corticosteroids with long acting Beta 2 agonist are given to control group patients twice daily

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-02
Primary Completion
2025-11-02
Completion
2025-11-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06721247 on ClinicalTrials.gov